Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd (FTRP.TO)

Field Trip Health Ltd (FTRP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Field Trip Health Ltd 30 Duncan Street Suite 401 Toronto ON M5V 2C3 CAN

P: 833-833-1967

Description:

Field Trip Health Ltd is engaged in the development and delivery of psychedelic therapies. Its operating segments include Clinical Operations, Research, and Corporate. With its Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules and researching plant-based psychedelics and its Field Trip Health division building centers for psychedelic therapies. Its geographical segments are Canada, the United States, and Jamaica.

Key Statistics

Overview:

Market Capitalization, $K 63,386
Shares Outstanding, K 11,630
Annual Sales, $ 4,860 K
Annual Net Income, $ -54,691 K
Last Quarter Sales, $ 1,724 K
Last Quarter Net Income, $ -14,170 K
% of Institutional Shareholders 3.59%

Growth:

1-Year Return -82.64%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date 08/15/22
Earnings Per Share ttm -4.75
EPS Growth vs. Prev Year 65.11%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 08/17/22

FTRP.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -60.59%
Return-on-Assets % -47.85%
Profit Margin % -1,125.30%
Debt/Equity 0.40
Price/Sales 12.95
Price/Book 0.95
Book Value/Share 5.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar